This is reinforced by our findings that treatment with the selective iNOS inhibitor aminoguanidine reduced obesity-associated IR and OVA-induced eosinophilic inflammation in obese mice in a similar fashion to metformin. This evidence concerns the gene NOS2 and Obesity.